未登录

G

G Turpin

H指数:30

被引数:4,084

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adrenal insufficiency after adrenal hemorrhage

肾上腺出血后肾上腺功能不全

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

IF3.5

2014-04-132

PREAI

Effect of levothyroxine replacement therapy on coagulation and fibrinolysis in severe hypothyroidism

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

IF3.5

2014-03-2825

PREAI

Pituitary carcinoma: Report of an exceptional case and review of the literature

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

IF3.5

2014-03-1127

PREAI

Common promoter C516T polymorphism in the ApoB gene is an independent predictor of carotid atherosclerotic disease in subjects presenting a broad range of plasma cholesterol levels

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2004-11-0119

PREAI

Common polymorphism in the MTP promoter attenuates the dyslipidemic and proatherogenic effects of excess body weight

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2004-08-014

PREAI

Relationship of circulating C-reactive protein levels to thyroid status and cardiovascular risk in hyperlipidemic euthyroid subjects: low free thyroxine is associated with elevated hsCRP

ATHEROSCLEROSIS

IF5.7

2004-01-0132

PREAI

Magnitude of HDL cholesterol variation after high-dose atorvastatin is genetically determined at the LDL receptor locus in patients with homozygous familial hypercholesterolemia

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2003-11-016

PREAI

A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients

METABOLISM-CLINICAL AND EXPERIMENTAL

IF11.9

2002-08-0139

PREAI

Smaller LDL particle size in women with polycystic ovary syndrome compared to controls

CLINICAL ENDOCRINOLOGY

IF2.4

2002-01-1278

PREAI

Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2001-12-01117

OAAI

Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia

ATHEROSCLEROSIS

IF5.7

2001-02-0185

PREAI

Liver fibrosis in overweight patients

GASTROENTEROLOGY

IF25.1

2000-06-01804

OA

Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI Paris

ATHEROSCLEROSIS

IF5.7

2000-02-0145

PREAI

Relationship between triglycerides and factor VIIc and plasminogen activator inhibitor type-1: Lack of threshold value

THROMBOSIS RESEARCH

IF3.4

1999-11-0120

PREAI

Cysteine is a cardiovascular risk factor in hyperlipidemic patients

ATHEROSCLEROSIS

IF5.7

1999-09-01104

PREAI

Effects of a low-calorie diet on resting metabolic rate and serum tri-iodothyronine levels in obese children

EUROPEAN JOURNAL OF PEDIATRICS

IF2.6

1999-05-0545

PREAI

Interrelationships between postprandial lipoprotein B:CIII particle changes and high-density lipoprotein subpopulation profiles in mixed hyperlipoproteinemia

METABOLISM-CLINICAL AND EXPERIMENTAL

IF11.9

1999-01-0122

PREAI

Hyperalphalipoproteinemia:: Characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity

METABOLISM-CLINICAL AND EXPERIMENTAL

IF11.9

1998-08-0125

PREAI

Characterization of two HDL subfractions and LpA-I, LpA-I:A-II distribution profiles and clinical characteristics of hyperalphalipoproteinemic subjects without cholesterol ester transfer protein deficiency.

ATHEROSCLEROSIS

IF5.7

1998-06-016

PREAI

Is there a threshold level of triglyceride above which factor VIIc and plasminogen activator inhibitor type 1 are elevated?

ATHEROSCLEROSIS

IF5.7

1997-10-010

PREAI